|
ISIN No
|
INE406A01037
|
BSE Code / NSE Code
|
524804 / AUROPHARMA
|
Book Value (Rs.)
|
670.19
|
Face Value
|
1.00
|
|
Bookclosure
|
17/04/2026
|
52Week High
|
1740
|
EPS
|
60.34
|
P/E
|
27.62
|
|
Market Cap.
|
96813.82 Cr.
|
52Week Low
|
1080
|
P/BV / Div Yield (%)
|
2.49 / 0.24
|
Market Lot
|
1.00
|
|
Security Type
|
Other
|
|
You can view the investment break up of the company with details such as Security name, Security type, Company type, investmement cost etc.
| YearEnd | Security Name | Security Type | Company Type | Cost of Investments |
| 2603 |
Curateq Biologics Pvt. Ltd.
| Debenture | Subsidiary | 4139.89 |
| 2603 |
Lyfius Pharma Pvt. Ltd.
| Debenture | Subsidiary | 3487.81 |
| 2603 |
Apitoria Pharma Pvt. Ltd.
| Debenture | Subsidiary | 2850.00 |
| 2603 |
Helix Healthcare B.V.
| Equity Share | Subsidiary | 2310.74 |
| 2603 |
Qule Pharma Pvt. Ltd.
| Debenture | Subsidiary | 790.74 |
| 2603 |
Eugia Pharma Specialties Ltd.
| Equity Share | Subsidiary | 732.78 |
| 2603 |
SBI Mutual Funds
| Mutual Fund Scheme | Mutual Fund | 726.18 |
| 2603 |
Auro Active Pharma Pvt. Ltd.
| Debenture | Subsidiary | 562.83 |
|